EcoDrugPlus

Ensembl ID : ENSATEG00000021546
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSATEG00000022462
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSATEG00000025126
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSATEG00000005392
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSATEG00000020764
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSATEG00000026219
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSATEG00000023599
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSATEG00000026649
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSATEG00000020418
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSATEG00000027947
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSATEG00000020667
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSATEG00000004568
Gene Symbol: -
Cross references: -
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).